Avalyn Pharma
The Director, Clinical Development Research Scientist will serve as a key clinical and scientific leader advancing the company's IPF/ILD clinical development programs. This role involves providing therapeutic-area expertise and strategic leadership across the development lifecycle, from program and study strategy through protocol design, clinical execution, and regulatory interactions. The position requires leading clinical trials and partnering with cross-functional teams to ensure scientific rigor, patient focus, and alignment with broader program objectives.
Avalyn Pharma Inc is a clinical-stage biopharmaceutical company developing inhaled therapies to treat rare respiratory diseases, including pulmonary fibrosis and other interstitial lung diseases. The company's approach focuses on delivering inhaled formulations of established medicines directly to lung tissue to potentially enhance efficacy and reduce systemic side effects. Its pipeline includes two clinical-stage programs, AP01 (inhaled pirfenidone) and AP02 (inhaled nintedanib), as well as a preclinical program, AP03, a fixed-dose combination of both agents.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Avalyn Pharma.
Avalyn Pharma
Aug 5, 2025
Senior Clinical Scientist
CRISPR Therapeutics
Senior Clinical Scientist
Merck & Co., Inc.
Principal Clinical Research Scientist
Abbott Laboratories
Clinical Scientist Associate Director – Cardiovascular Trials
lifelancer
Clinical Scientist
Zymeworks
Global Pain Clinical Research Scientist (CRS)
Eli Lilly and Company